Honglin Jin

20PUBLICATIONS
36CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteinsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jun 29, 2026
Single-cell profiling of gastric cancer ascites reveals an epithelial-immune dual phenotype signature predictive for anti-PD-1 immunotherapy responses.

|Apr 16, 2026
Enhancing antitumour nanovaccine efficacy via integrated cholesterol modulation in situ.

|Nov 28, 2025
Supramolecular dyes: advancing precision medicine through molecular engineering.

Jun Li, Yuling Xu, Yida Pang

|Sep 10, 2025
Immunotherapies for Aging and Age-Related Diseases: Advances, Pitfalls, and Prospects.

Muyang Yang, Shipeng Wu, Jiasi Zhang

|Mar 07, 2025
The cGAS-STING pathway in cancer immunity: dual roles, therapeutic strategies, and clinical challenges.

Beilei Yue, Wenbo Gao, Jonathan F Lovell

|Dec 23, 2024
Tumor cell membrane-based vaccines: A potential boost for cancer immunotherapy.

Muyang Yang, Jie Zhou, Liseng Lu

Pageof 4

Frequent Collaborators

8 joint publications

Jonathan F Lovell

3 joint publications

Yajie Sun

3 joint publications

Kunyu Yang

2 joint publications

Zushun Xu